Chr. Olesen Group

What Chr. Olesen Group does

Chr. Olesen Group is a fifth-generation, family-owned Danish ingredients distribution company founded in 1885 in Gentofte, Denmark. It distributes specialty ingredients to four end-markets: animal feed (animal nutrition and pet food), human food and nutrition, human and veterinary pharmaceuticals (active pharmaceutical ingredients, intermediates, and fine chemicals), and technical industries (polymers and technical minerals). The group operates roughly 15 wholly-owned subsidiaries and sales offices in Denmark, Germany, Belgium, Spain, France, Turkey, the United States (New York and Durham, NC), Brazil, Mexico, Colombia, and Peru, and uses agents in China and India. The product portfolio spans vitamins, amino acids, minerals, carotenoids, antioxidants, acidulants, hydrocolloids, proteins, botanicals, APIs, excipients, silanes, grafted polymers, polycarbonates, polylactic acid, and industrial minerals. Sourcing is supplemented by Chr. Olesen Synthesis A/S, a Denmark-based API manufacturing facility, and by exclusive distribution arrangements with strategic partners including Zhejiang NHU (Latin America) and iPOOL (polymers).

The company's technology and quality infrastructure centers on regulatory compliance and supply chain execution rather than proprietary software. It maintains ISO 9001:2015, FAMI-QS, FCA Ovocom, HACCP, EU GDP, GMP (via ACTIVET GmbH), REACH, CLP/GHS, EcoVadis, and Sedex certifications, with a dedicated Qualified Person (Dr. Heinrich Koch) overseeing pharma QA. Logistics are handled through a network of regional warehouses and trusted carriers, with no public-facing API, no digital product surface, and no AI/ML capabilities disclosed. Distribution is executed by dedicated industry specialists for each of the four verticals, supported by participation in five major industry trade shows annually (Vitafoods, Food Tech Summit, CPHI, SupplySide West, Food & Health Ingredients).

Chr. Olesen earns revenue primarily through distribution margins (transaction-fee model) on sourced and delivered ingredients. Pricing is quote-based and not publicly disclosed; customers contact industry specialists directly. Revenue streams are split across six documented lines: feed ingredients, human nutrition/food ingredients, human pharma APIs, veterinary pharma APIs, polymers and technical ingredients, and technical minerals. The company is privately held by the Olesen family, with no external parent, PE, or VC investment disclosed, and the most recent inorganic action is the October 2025 merger of its US subsidiary with Lalilab, Inc.

Name

Chr. Olesen Group

Legal name

Chr. Olesen A/S

Website

https://chr-olesen.dk

Company type

Private

Founded year

1885

Operating status

Operating

Headcount range

51–100 employees

Short description

Chr. Olesen Group is a fifth-generation, family-owned Danish specialty ingredients distributor (founded 1885) that supplies vitamins, amino acids, APIs, polymers, and minerals to the feed, food, pharmaceutical, and technical industries through owned subsidiaries across Europe, the Americas, and Turkey.

Ownership category

akta.pro rank

Product category

Specialty Ingredients Distribution

NAICS

Chemical and Allied Products Merchant Wholesalers (4246), Other Chemical and Allied Products Merchant Wholesalers (42469), Medicinal and Botanical Manufacturing (325411)

SIC

Wholesale-Chemicals & Allied Products (5160), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Food And Kindred Products (2000)

akta.pro primary industry

Extracts, Oleoresins & Essential Oils (Spice Extracts for Flavoring) (AFAJANAJ)

akta.pro secondary industries

Malic Acid & Malates (AFAJAGAE), High-Oleic & Specialty Oilseed Oils (AFAJALAC)

Keywords

• Specialty ingredients distribution
• Pharmaceutical API distribution
• Animal feed ingredients
• Human nutrition ingredients
• Polymer and mineral distribution

Headquarters

HQ city

Gentofte

HQ country

Denmark

HQ region

Europe

Offices14 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Feed Ingredients Distribution: Distribution of vitamins, amino acids, minerals, carotenoids, and antioxidants to animal feed producers and pre-mixers worldwide. Revenue is generated through margins on sourced and distributed feed ingredients.
2. Human Nutrition / Food Ingredients Distribution: Distribution of a broad range of ingredients including vitamins, acidulants, sweeteners, preservatives, flavor enhancers, minerals, botanicals, hydrocolloids, proteins, amino acids, antioxidants, and nutritional oils to the food, beverage, cosmetic, pharmaceutical, and supplement industries worldwide.
3. Human Pharma APIs Distribution: Distribution of active pharmaceutical ingredients for analgesics, anthelminthics, antihistamines, antibiotics, hormones, narcotic precursors, vitamins with DMF, and excipients to global pharmaceutical producers.
4. Veterinary Pharma APIs Distribution: Distribution of veterinary APIs including analgesics, anthelminthics/antiparasitics, antibiotics, hormones, vitamins with DMF, and excipients. Sourced from qualified manufacturers worldwide and from the company's own factory Chr. Olesen Synthesis A/S in Denmark.
5. Polymers and Technical Ingredients Distribution: Distribution of functional polymers, base resins, and technical ingredients including grafted polymers (MAH & GMA), polycarbonates, polyamides, polylactic acid, polybutene-1, and other polymer products to technical industries worldwide.
6. Technical Use of Minerals Distribution: Distribution of minerals for use in agriculture, oil drilling fluids, personal care & detergents, metal coating & electroplating, electrolysis, pigments & paints, pulp & paper, zeolite production, biotechnology, carrageenan, ABS plastics, and glass manufacturing.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels1 record

Core offering

Chr. Olesen Group is a global ingredients distribution company that sources, qualifies, and distributes vitamins, amino acids, minerals, carotenoids, antioxidants, active pharmaceutical ingredients (APIs), pharmaceutical intermediates, polymers, and industrial minerals to manufacturers in the feed, food, pharmaceutical, and technical industries. The company operates through wholly-owned subsidiaries across Europe, the Americas, and agents in Asia, supported by a global logistics and warehousing network and its own API manufacturing facility (Chr. Olesen Synthesis A/S) in Denmark.

Product overview

Chr. Olesen Group is a fifth-generation Danish family-owned global ingredients distribution company established in 1885, operating as a unified distribution platform across four interconnected business divisions: Feed (Animal Nutrition and Pet Food ingredients), Food (Human Nutrition ingredients), Pharma (Human APIs, Animal APIs, and Intermediates & Chemicals), and Technical Industries (Polymers and Technical Use of Minerals). The company distributes high-quality ingredients to customers worldwide from offices in Europe, Latin America, and the USA, serving feed, food, pharmaceutical, and technical industry sectors. The product portfolio includes vitamins, minerals, amino acids, proteins, polymers, minerals, APIs, and various specialty ingredients, with a focus on quality assurance, reliable supply chains, and long-term partnerships with manufacturers and customers.

Differentiator

Problem solved

Functional benefit

Products and services

• Animal Nutrition Ingredients Distribution of vitamins, amino acids, minerals, carotenoids, and antioxidants to animal feed producers and pre-mixers worldwide, supporting animal health, growth, and well-being.
• Pet Food Ingredients Distribution of high-quality ingredients for pet food including amino acids, hydrocolloids, oils, proteins, minerals, fibers, vitamins, antioxidants, acidulants, botanicals, and other nutritional ingredients to support pet health and nutrition.
• Human Nutrition Ingredients Distribution of a broad range of food ingredients including vitamins (fat-soluble and water-soluble), acidulants, sweeteners, preservatives, flavor enhancers, minerals, botanicals, hydrocolloids, proteins, amino acids, antioxidants, and nutritional oils to food, beverage, cosmetic, pharmaceutical, and supplement industries worldwide.
• Human APIs (Active Pharmaceutical Ingredients) Distribution of active pharmaceutical ingredients for human pharmaceuticals including analgesics, anthelminthics, antihistamines, antibiotics, hormones, narcotic precursors, vitamins with DMF, and excipients to pharmaceutical producers worldwide.
• Animal APIs (Veterinary Pharmaceutical Ingredients) Distribution of veterinary pharmaceutical APIs including analgesics, anthelminthics/antiparasitics, antibiotics, hormones, vitamins with DMF, excipients, and miscellaneous products to maintain animal health. Sourced from qualified manufacturers worldwide and from the company's own factory Chr. Olesen Synthesis A/S in Denmark.
• Pharma Intermediates & Chemicals Sourcing and distribution of pharmaceutical intermediates, starting materials, fine chemicals, raw materials, solvents, and silanes for pharmaceutical and chemical industry customers, meeting quality standards up to GMP level.
• Polymers Distribution of high-quality polymers including grafted polymers (MAH & GMA), polycarbonates, polyamides, polylactic acid, polybutene-1, reactor thermoplastic polyolefins, and other base resins for innovative and sustainable compounds.
• Technical Use of Minerals Distribution of mineral products for various technical applications including agriculture, oil drilling fluids, personal care & detergents, metal coating & electroplating, electrolysis, pigments & paints, pulp & paper, zeolite production, biotechnology, carrageenan, ABS plastics, and glass manufacturing.

Segments7 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• Lalilab, Inc.coreStrategic or Co-development Partner · 8 October 2025Chr. Olesen's US subsidiary merged with Lalilab, Inc., a family-owned North Carolina corporation specializing in pharmaceutical, nutraceutical, and food ingredient sourcing. The deal, arranged by M&A advisor ThinkingLinking, combines two family-owned businesses with strong histories in ingredients distribution. The merger expands Chr. Olesen's US footprint while giving Lalilab access to a broader range of food and pharma-related products through Chr. Olesen's global network.
• Zhejiang NHU (China)coreStrategic or Co-development PartnerChr. Olesen's feed business in Brazil and Mexico is closely connected to an important partnership with Zhejiang NHU, a leading Chinese ingredients company. This partnership underpins the NHU/CHR. Olesen Latin America joint operations, combining Chinese manufacturing capabilities with Chr. Olesen's global distribution network.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Brenntag: World's largest chemical and ingredients distributor with multi-vertical coverage including food, pharma, and specialty ingredients. Comparable as a global full-line distributor; Chr. Olesen is a much smaller, more family-driven version operating in overlapping categories.
• Univar Solutions: North American-headquartered global distributor of chemicals and ingredients across life sciences, food, and industrial end-markets. Comparable in product breadth across pharma/food/industrial ingredients, though at materially larger scale.

Direct peers

• IMCD: Dutch-headquartered specialty chemicals and ingredients distributor with deep pharma, food, and personal care coverage. Closest functional peer in terms of specialty distribution model, EMEA heritage, and multi-vertical structure.
• Azelis: Belgian-headquartered specialty distributor focused on food, pharma, personal care, and industrial specialties. Comparable vertical mix and European family-business origins, with an explicit M&A roll-up strategy that mirrors Chr. Olesen's Lalilab move.
• Barentz: Dutch distributor focused on food, nutrition, personal care, and animal nutrition ingredients. Directly comparable to Chr. Olesen's food, feed, and pharma distribution business, with similar family-business DNA and PE-backed growth.
• Caldic: Dutch ingredients solutions provider serving food, personal care, and pharma markets globally. Highly comparable multi-vertical specialty ingredients distribution model; was itself a family-owned business before Advent International acquisition.
• DKSH: Swiss-headquartered market expansion services company distributing ingredients and chemicals across Asia-Pacific and Europe. Comparable as a regional specialty distributor serving food, pharma, and industrial customers, with a different geographic center of gravity.

Emerging players

• Hawkins: US specialty chemical and ingredients distributor serving industrial, water treatment, and food/pharma markets. Comparable in distribution-led business model and regulatory compliance focus, though smaller and more US-centric than Chr. Olesen.
• ICC Chemical: Global distributor of specialty chemicals and ingredients serving industrial, pharma, and consumer markets. Comparable as a privately-held specialty ingredients distributor; smaller and less diversified vertically than Chr. Olesen.

Regional players

• Manuchar: Belgian-headquartered global distributor of chemicals and ingredients with strong emerging-market presence in LATAM, Africa, and Asia. Comparable as a family-owned ingredients distributor with emerging-markets focus, but with different geographic concentration.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/chr-olesen-group

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles22 records

Subsidiaries27 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chr. Olesen Group